Overview

A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations

Status:
Completed

Trial end date:
2018-06-28

Target enrollment:

Participant gender:

Summary

A Phase 1, Crossover Study to Evaluate the Pharmacokinetics of Corplex™ Donepezil 10 mg Transdermal Delivery System Applied to Different Body Locations

Phase:

Phase 1

Details

Lead Sponsor:

Corium International Inc.
Corium, Inc.

Treatments:

Donepezil